EARLY ALZHEIMER'S DISEASE
Clinical trials for EARLY ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for EARLY ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to slow Alzheimer's progression in major trial
Disease control Recruiting nowThis study is testing whether an experimental tablet called TTYP01 can slow the progression of early Alzheimer's disease. Researchers will enroll 180 people with mild memory problems due to Alzheimer's and randomly assign them to receive either one of two doses of TTYP01 or a pla…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Shanghai Auzone Biological Technology Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug aims to slow Alzheimer's brain damage
Disease control Recruiting nowThis study is testing whether an experimental drug called MK-2214 can slow the progression of early Alzheimer's disease. Researchers will enroll 340 people with mild memory problems or early dementia to receive either the drug or a placebo. The main goal is to see if MK-2214 redu…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC